Radiobiological comparison between Cobalt‐60 and Iridium‐192 high‐dose‐rate brachytherapy sources: Part I—cervical cancer

M Dayyani, E Hoseinian‐Azghadi… - Medical …, 2021 - Wiley Online Library
Purpose This study aimed to compare the biological effective doses (BEDs) to clinical target
volume (CTV) and organs at risk (OARs) for cervical cancer patients treated with high‐dose …
被引用次数：4 相关文章

Radiobiological comparison between Cobalt-60 and Iridium-192 high-dose-rate brachytherapy sources: Part I-cervical cancer

M Dayyani, E Hoseinian-Azghadi… - Medical …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose This study aimed to compare the biological effective doses (BEDs) to clinical target
volume (CTV) and organs at risk (OARs) for cervical cancer patients treated with high-dose …

Radiobiological comparison between Cobalt-60 and Iridium-192 high-dose-rate brachytherapy sources: Part I-cervical cancer.

M Dayyani, E Hoseinian-Azghadi… - Medical …, 2021 - europepmc.org
Purpose This study aimed to compare the biological effective doses (BEDs) to clinical target
volume (CTV) and organs at risk (OARs) for cervical cancer patients treated with high-dose …

Radiobiological comparison between Cobalt‐60 and Iridium‐192 high‐dose‐rate brachytherapy sources: Part I—cervical cancer

M Dayyani, E Hoseinian-Azghadi… - Medical …, 2021 - profdoc.um.ac.ir
Purpose: This study aimed to compare the biological effective doses (BEDs) to clinical target
volume (CTV) and organs at risk (OARs) for cervical cancer patients treated with high-dose …

[引用][C] Radiobiological comparison between Cobalt‑60 and Iridium‑192 high‑dose‑rate brachytherapy sources: Part I—cervical cancer

M Dayyani, E Hoseinian-Azghadi… - Medical …, 2021 - ui.adsabs.harvard.edu
Radiobiological comparison between Cobalt‑60 and Iridium‑192 high‑dose‑rate brachytherapy
sources: Part I—cervical cancer - NASA/ADS Now on home page ads icon ads Enable full ADS …

Radiobiological comparison between Cobalt‐60 and Iridium‐192 high‐dose‐rate brachytherapy sources: Part I—cervical cancer

M Dayyani, E Hoseinian-Azghadi… - Medical …, 2021 - profdoc.um.ac.ir
Purpose: This study aimed to compare the biological effective doses (BEDs) to clinical target
volume (CTV) and organs at risk (OARs) for cervical cancer patients treated with high-dose …